Clinical trial
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes…
NCT00419562 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00419562 |
|---|---|
| Title | Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus |
| Official title | Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus |
| Acronym | TN07 |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH National Institute of Allergy and Infectious Diseases (NIAID) National Center for Research Resources (NCRR)… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | Oral Insulin, Placebo |
| Enrollment | 560 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2016 |
| Completion | Jun 1, 2017 |
| First posted | Jan 8, 2007 |
| Last update posted | May 7, 2020 |
| Countries | Australia, Canada, Finland, Italy, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: